Search results
France’s Sanofi in COVID-19 vaccine deal with Novavax
WHTC 1450 Holland· 6 days agoPARIS (Reuters) - Sanofi on Friday announced it has reached a licensing agreement with Novavax to...
There might be stockpiles, but making an effective bird flu vaccine won’t be quick or easy
The Telegraph via Yahoo News· 1 day agoHealth officials have been steadfast in their assurances. The risk of H5N1 bird flu jumping into...
Moderna’s First Vaccine Was a Big Hit. Its Second Is a Let Down
Bloomberg via Yahoo Finance· 7 days ago(Bloomberg) -- Moderna Inc.’s pioneering Covid shot turned the company into a nearly $200 billion...
Decoding Pfizer Inc (PFE): A Strategic SWOT Insight
GuruFocus.com via Yahoo Finance· 6 days agoAdvancements in Biopharmaceutical R&D: The company's robust R&D pipeline, supported by a substantial investment of $2,493 million in the first quarter of...
The AstraZeneca vaccine – should you be worried?
Daily Telegraph· 5 days agoEarlier this week, the European Commission announced that the Covid-19 vaccine, developed as part of a collaboration between the British pharma company...
Was COVID vaccine recalled over health danger fears? What we know
Newsweek· 7 days agoPharmaceutical company AstraZeneca has initiated a global withdrawal of its COVID-19 vaccine just...
Novavax stock soars 40% on Sanofi partnership
Investing.com· 6 days agoThe company's revenue was $93.85 million, significantly falling short of the consensus estimate of $141.16 million. Despite missing Q1 estimates, NVAX...
AstraZeneca’s COVID vaccine withdrawn – right to the end it was the victim of misinformation -...
EconoTimes· 7 days agoThe Oxford-AstraZeneca vaccine was a critical part of the COVID-19 pandemic response. This EU...
National Academies Report: COVID-19 Vaccines Don’t Cause Many Potential Harms
Journal of the American Medical Association· 6 days agoThe COVID-19 vaccines made by Pfizer-BioNTech and Moderna do not cause such conditions as female infertility, myocardial infarction, Bell palsy, or Guillain-Barré ...
The WHO’s naive global vaccine plan won’t withstand contact with reality
The Telegraph via Yahoo News· 6 days agoThe AstraZeneca vaccine was, for a while, the most celebrated product in Britain. The UK was one of...